Drug profile · INN
mycophenolate sodium
MYCOPHENOLATE SODIUM
mycophenolate sodium (MYCOPHENOLATE SODIUM) is a inosine-5'-monophosphate dehydrogenase (impdh) inhibitor. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Drug details — mycophenolate sodium
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 1
- Programs
- 2
- Data quality
- 0.89
Quick answer
mycophenolate sodium (MYCOPHENOLATE SODIUM) is a inosine-5'-monophosphate dehydrogenase (impdh) inhibitor. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor
Primary target: Inosine-5'-monophosphate dehydrogenase (IMPDH)
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is mycophenolate sodium?
mycophenolate sodium (MYCOPHENOLATE SODIUM) is a inosine-5'-monophosphate dehydrogenase (impdh) inhibitor. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for mycophenolate sodium?
MYCOPHENOLATE SODIUM is a marketed brand name for mycophenolate sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of mycophenolate sodium?
mycophenolate sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.